Bone Growth Stimulators Market To Surpass US$ 2,975.5 Million By 2027 - Coherent Market Insights


Posted October 10, 2020 by SANJAYCMI

Bone Growth Stimulator Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
 
Bone growth stimulation may involve the use of invasive, semi-invasive or non-invasive techniques. Some of the types of bone growth stimulators include, non-invasive electrical bone growth stimulators, invasive electrical bone growth stimulators, and ultrasound bone growth stimulators.

Statistics: The global bone growth stimulators market is estimated to account for US$ 1,435.1 Mn in terms of value and 572,592 Units in terms of volume by the end of 2019 Global Bone Growth

Stimulators Market: Drivers Increasing sports activities and resulting sport injuries is expected to boost growth of the global bone growth stimulators market over the forecast period. For instance, according to the National High School Sports-Related Injury Surveillance Study 2017-2018, 1,367,490 cases of sport-related were recorded in high schools in the U.S.

Global Bone Growth Stimulators Market: Opportunities R&D in bone regeneration is expected to offer lucrative growth opportunities for market players. For instance, in June 2019, researchers from Meiji University and Keio University in Japan, reported fabrication of biomimetic-engineered bone using connective tissue growth factor (CTGF), a multifunctional protein.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/bone-growth-stimulator-market-225

Global Bone Growth Stimulators Market: Restraints However, bone growth stimulators have a limited battery life of six to eight months and are prone to short circuiting. Placing hardware in some patients is also challenging and there is a possibility of infection and the need for a second procedure for removal of the implanted devices. Such factors are expected to hinder growth of the global bone growth stimulators market.

Key Takeaways:

The Noninvasive Electrical Bone Growth Stimulators segment in the global bone growth stimulators market was valued at US$ 660.1 Mn in 2018 and is expected to reach US$ 1,528.3 Mn by 2027 at a CAGR of 9.8% during the forecast period.The growth of the segment is attributed to increasing product launches and increasing incidence of sports injury The Trauma injury and Fractures segment held dominant position in the global bone growth stimulators market in 2018, accounting for 45.1% share in terms of volume, followed by Spinal Fusion, respectively. Increasing prevalence of osteoporosis and osteoarthritis is expected to boost growth of the segment

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/225

Market Trends Increasing demand for non-surgical treatment, especially in the geriatric population group is expected to boost growth of the market over the forecast period. Bone growth stimulators can aid in the healing of bones without the need of painful surgery. Key players in the market are offering their products online for sell as well as rent through e-commerce partners such as Amazon.com Inc., and eBay Inc. For instance, Medi-Rent Pty. Ltd., a provider of medical and maternity rental equipment, offers bone growth stimulators on rent.

Global Bone Growth Stimulators Market: Competitive Landscape Major players operating in the global bone growth stimulators market include, DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Precyse Solutions LLC., Ossatec Benelux BV, Verve Consulting Inc., and IGEA S.p.A.

Key players in the market are focused on product approval and launch to expand their product portfolio. For instance, in December 2019, Royal Biologics announced the U.S. commercial launch of Maxx Ultra Cord, a maximum natural thickness allograft derived from umbilical cord. In March 2018, Orthofix International N.V. announced the U.S. Food and Drug Administration (FDA) and European CE Mark approvals for its next-generation PhysioStim bone growth stimulators. Segmentation

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/225

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags bone growth stimulator , bone growth stimulator market analysis , bone growth stimulator market outlook
Last Updated October 10, 2020